GILD

Gilead Sciences Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth 9/10
  • Value 3/10
Gilead Sciences sales and earnings growth
GILD Growth
Great
  • Revenue Y/Y 3.81%
  • EPS Y/Y 55.56%
  • FCF Y/Y 3.92%
Gilead Sciences gross and profit margin trends
GILD Profitability
Great
  • Gross margin 79.40%
  • EPS margin 31.00%
  • ROIC 5Y 19.33%
Gilead Sciences recent dividend growth
GILD Dividends
  • Dividend yield 2.44%
  • Growth 3Y 2.78%
  • Payout ratio 43%
Gilead Sciences net debt vs free cash flow
GILD Risk
Great
  • Debt / Equity 0.9
  • Debt / FCF 1.4
  • Interest coverage 11.7

Gilead Sciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - General stocks